Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yu-xia Wei
Exosomal lncRNA HNF1A-AS1 Affects Cisplatin Resistance in Cervical Cancer Cells Through Regulating microRNA-34b/TUFT1 Axis
Cancer Cell International
Cancer Research
Oncology
Genetics
Related publications
LncRNA MALAT1 Potentiates Autophagy‑associated Cisplatin Resistance by Regulating the microRNA‑30b/autophagy‑related Gene 5 Axis in Gastric Cancer
International Journal of Oncology
Cancer Research
Oncology
Knockdown of lncRNA HNF1A-AS1 Inhibits Oncogenic Phenotypes in Colorectal Carcinoma
Molecular Medicine Reports
Oncology
Genetics
Molecular Biology
Biochemistry
Cancer Research
Molecular Medicine
LncRNA TATDN1 Contributes to the Cisplatin Resistance of Non-Small Cell Lung Cancer Through TATDN1/miR-451/TRIM66 Axis
Cancer Biology and Therapy
Cancer Research
Oncology
Molecular Medicine
Pharmacology
AFAP1‑AS1 Induces Cisplatin Resistance in Non‑small Cell Lung Cancer Through PI3K/AKT Pathway
Oncology Letters
Cancer Research
Oncology
LncRNA NEAT1 Enhances the Radio-Resistance of Cervical Cancer via miR-193b-3p/CCND1 Axis
Oncotarget
Oncology
Exosomal Transfer of Cisplatin-Induced miR-425-3p Confers Cisplatin Resistance in NSCLC Through Activating Autophagy
International Journal of Nanomedicine
Organic Chemistry
Biophysics
Biomaterials
Pharmaceutical Science
Medicine
Bioengineering
Drug Discovery
Nanoscience
Nanotechnology
Transcriptome Profiling of Cervical Cancer Cells Acquired Resistance to Cisplatin by Deep Sequencing
Artificial Cells, Nanomedicine and Biotechnology
Medicine
Biotechnology
Biomedical Engineering
Pharmaceutical Science
P2.03-31 LncRNA RGMB-AS1 Affects Lung Adenocarcinoma Prognosis by Regulating Microtube Associated Genes: A Genome-Wide Analysis in Silicon
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Exosomal Lipids Induce Human Pancreatic Tumoral MiaPaCa-2 Cells Resistance Through the CXCR-4SDF-1? Signaling Axis
Oncoscience
Cancer Research
Oncology